Bringing the good news on the amazing people in the lung cancer community making a difference.

I sat down with Dr. Yasir Elamin to get his thoughts on his presentation at ASCO regarding patient reported outcomes and health-related quality of life with Taletrectinib in advanced ROS1 non-small cell lung cancer (NSCLC) from the TRUST-II Study.

I sat down with Professor Sanjay Popat to get his thoughts on the ROSETTA Lung-02 abstract presented at ASCO and what it could mean for clinical practice, future research, and patient care.

I sat down with Dr. Nasser H. Hanna to get his thoughts on three lung cancer research abstracts presented at ASCO that he is most excited about, and what they could mean for clinical practice, future research, and patient care.